[Evaluation of 2-year treatment of Schnitzler syndrome (urticarial exanthema, monoclonal IgM gammopathy and osteolytic-osteosclerotic skeletal changes) using Anakinra (Kineret)].
Adam
Z
Z
Krejcí
M
M
Pour
L
L
Hájek
R
R
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008297:Male; D019873:Schnitzler Syndrome / Q000188:drug therapy*
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein